Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aura Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +6 vs. Q3 2022
- Shares held
- 23.8M
- +7.49M (+45.9%) vs. Q3 2022
- Total value
- $250.0M
- −$45.6M (−15.4%) vs. Q3 2022
- New holders
- 12
- 21 more added
- Sold out
- 6
- 10 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Credit Suisse AG | 1 | $11 | 0.00% | −102−99.0% | Reduced |
| UBS Group AG | 1,104 | $11.6K | 0.00% | −11,163−91.0% | Reduced |
| Metropolitan Life Insurance Co | 1,280 | $13.4K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,374 | $14.6K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 2,256 | $23.7K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,681 | $28.0K | 0.00% | +2,458+1,102.2% | Added |
| Amalgamated Bank | 2,941 | $31.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,535 | $37.0K | 0.00% | +2,273+180.1% | Added |
| California State Teachers Retirement System | 7,316 | $76.8K | 0.00% | +83+1.1% | Added |
| Deutsche Bank AG | 8,159 | $85.7K | 0.00% | +124+1.5% | Added |
| American International Group, Inc. | 8,668 | $91.0K | 0.00% | −32−0.4% | Reduced |
| JPMorgan Chase & Co | 10,746 | $113.0K | 0.00% | +733+7.3% | Added |
| MetLife Investment Management | 11,026 | $115.8K | 0.00% | 00.0% | Unchanged |
| CVI Holdings, LLC | 12,592 | $132.2K | 0.02% | +12,592 | New |
| Renaissance Technologies LLC | 13,100 | $138.0K | 0.00% | +13,100 | New |
| New York State Common Retirement Fund | 14,462 | $151.9K | 0.00% | −10−0.1% | Reduced |
| Alyeska Investment Group, L.P. | 21,456 | $225.3K | 0.00% | +21,456 | New |
| Rhumbline Advisers | 22,670 | $238.0K | 0.00% | +331+1.5% | Added |
| Water Island Capital LLC | 23,500 | $246.8K | 0.02% | +12,800+119.6% | Added |
| Alps Advisors Inc | 24,432 | $256.5K | 0.00% | +24,432 | New |
| Bank of Montreal | 19,429 | $273.8K | 0.00% | +19,429 | New |
| Bank of America Corp | 27,215 | $285.8K | 0.00% | −18,024−39.8% | Reduced |
| Barclays PLC | 36,519 | $383.5K | 0.00% | −5,525−13.1% | Reduced |
| Manufacturers Life Insurance Company, The | 42,585 | $442.3K | 0.00% | +42,585 | New |
| Charles Schwab Investment Management Inc | 47,807 | $502.0K | 0.00% | +804+1.7% | Added |
| Nuveen Asset Management, LLC | 49,039 | $515.0K | 0.00% | −12,685−20.6% | Reduced |
| Bank of New York Mellon Corp | 50,096 | $526.0K | 0.00% | −240−0.5% | Reduced |
| TD Asset Management Inc | 53,956 | $566.5K | 0.00% | +53,956 | New |
| Morgan Stanley | 64,603 | $678.3K | 0.00% | +9,451+17.1% | Added |
| Monashee Investment Management LLC | 131,640 | $1.38M | 0.59% | +131,640 | New |
| Northern Trust Corp | 143,815 | $1.51M | 0.00% | −1,286−0.9% | Reduced |
| Citigroup Inc | 145,704 | $1.53M | 0.00% | −4,036−2.7% | Reduced |
| Goldman Sachs Group Inc | 205,580 | $2.16M | 0.00% | +205,580 | New |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3.08M | 1.15% | +83,333+39.7% | Added |
| Geode Capital Management, LLC | 300,473 | $3.15M | 0.00% | +11,161+3.9% | Added |
| State Street Corp | 310,690 | $3.26M | 0.00% | +12,252+4.1% | Added |
| Artal Group S.A. | 410,000 | $4.30M | 0.25% | +410,000 | New |
| Regency Capital Management Inc. | 554,286 | $5.82M | 6.69% | +329,732+146.8% | Added |
| FMR LLC | 728,397 | $7.65M | 0.00% | +124,636+20.6% | Added |
| Price T Rowe Associates Inc | 739,215 | $7.76M | 0.00% | +739,215 | New |
| Nantahala Capital Management, LLC | 798,751 | $8.39M | 0.76% | +414,987+108.1% | Added |
| Vanguard Group Inc | 863,580 | $9.07M | 0.00% | +257,696+42.5% | Added |
| Rock Springs Capital Management LP | 1,019,757 | $10.7M | 0.26% | +4,000+0.4% | Added |
| BlackRock Inc. | 1,053,127 | $11.1M | 0.00% | +39,672+3.9% | Added |
| Adage Capital Partners GP, L.L.C. | 2,132,739 | $22.4M | 0.05% | +681,538+47.0% | Added |
| Eventide Asset Management, LLC | 2,251,368 | $23.6M | 0.47% | +2,251,368 | New |
| Citadel Advisors LLC | 2,737,053 | $28.7M | 0.03% | +424,735+18.4% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $31.9M | 13.41% | 00.0% | Unchanged |
| Matrix Capital Management Company, LP | 5,362,870 | $56.3M | 1.07% | +1,250,000+30.4% | Added |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −13,414−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −12,430−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,961−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −5,821−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −310−100.0% | Sold out |